Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. CapMan Oy and 3i Group – sale of NeoPharma AB to Solvay Pharmaceuticals
Mandate

CapMan Oy and 3i Group – sale of NeoPharma AB to Solvay Pharmaceuticals

May 10, 2005

Solvay Pharmaceuticals, the Belgium based pharmaceuticals firm, has agreed to acquire NeoPharma AB, the Sweden based pharmaceuticals firm involved in development of drugs for the treatment of Parkinson's disease, from 3i Group plc, the UK based private equity firm, and CapMan, the Finnish private equity firm, in a transaction, for approximately SEK 640m (EUR 71.26m).

Vinge acted for the sellers, being private investors as well as private equity funds including 3i and CapMan.
Anders Åberg, Malin Ohlin Åkermark (reponsible partners)
Maja Wettergren, Ola Sandersson (associates)

Related

Vinge has advised Terranor Group AB in connection with its listing on Nasdaq First North Growth Market

 Vinge has advised Terranor Group AB (publ) (“Terranor”) connection with its listing on Nasdaq First North Growth Market. The first day of trading in Terranor's shares is today 30 June 2025.
June 30, 2025

Vinge advises Keyto Group in connection with the acquisition of GreenThumb

KEYTO Group expands into the UK market as GreenThumb joins the group. This partnership marks KEYTO’s first entry in the UK and reinforces its ambition to build the leading, tech-enabled one-stop destination for home-related services internationally.
June 30, 2025

Vinge advises Odevo in the acquisition of Portik Group

 Vinge has advised Odevo, the internationally leading company within residential property management, in connection with the acquisition of Portik Group. Through the acquisition, Odevo continues its international expansion by establishing itself in Spain, Italy, Portugal and Mexico.
June 27, 2025